The therapeutic potential for phospholipase A2 inhibitors

Emerging Drugs

Volumn 3, Issue , 1998, Pages 333-344

  Mayer, R J ^a   Marshall, L A ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CARBOXYPHENYL) 3,7 DIMETHYL 9 (2,6,6 TRIMETHYL 1 CYCLOHEXENYL) 2,4,6,8 NONATETRAENOIC ACID; ANTIRHEUMATIC AGENT; ANTISENSE OLIGONUCLEOTIDE; BETAMETHASONE; CORTICOSTEROID; ETODOLAC; GOLD DERIVATIVE; HYDROCORTISONE; ISOENZYME; LEUKOTRIENE; LY 311727; METHOTREXATE; NABUMETONE; NONSTEROID ANTIINFLAMMATORY AGENT; OXAPROZIN; PENICILLAMINE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PREDNISONE; PROSTAGLANDIN; RO 23 9358; SB 203357; UNCLASSIFIED DRUG; YM 26734;

DRUG DESIGN; DRUG DEVELOPMENT; EDEMA; ENZYME INHIBITION; HUMAN; INFLAMMATORY DISEASE; MONOCYTE; NEUTROPHIL; PROSTAGLANDIN SYNTHESIS; REVIEW; RHEUMATOID ARTHRITIS;

EID: 0031958048     PISSN: 13619195     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728214.3.1.333     Document Type: Review

References (47)